|
American College of Radiology Imaging Network
|
2U01CA080098-10
|
$9,101,961
|
$455,098
|
Schnall, Mitchell
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
SV40 Pathogenesis of Human Infections
|
5R01CA104818-05
|
$467,229
|
$140,169
|
BUTEL, JANET
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-02S1
|
$117,286
|
$1,173
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-02
|
$1,515,000
|
$15,150
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
DF/HCC Renal Cancer SPORE
|
3P50CA101942-05S1
|
$1,165,299
|
$1,165,299
|
ATKINS, MICHAEL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Eastern Cooperative Oncology Group
|
5U10CA080775-10
|
$128,678
|
$10,294
|
ATKINS, MICHAEL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Enhanced RF Tumor Ablation with Liposomal Chemotherapy
|
5R01CA112533-05
|
$382,713
|
$126,295
|
GOLDBERG, S.
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
MAGIC ROUNDABOUT (MRB), A TUMOR ENDOTHELIAL MARKER
|
5K01CA104700-04
|
$153,629
|
$153,629
|
SETH, PANKAJ
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Novel vitamin D analog for kidney cancer
|
1R21CA127629-01A2
|
$182,813
|
$182,813
|
RAY, RAHUL
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Analgesic Use and Kidney Cancer
|
1R03CA137764-01
|
$87,083
|
$87,083
|
CHO, EUNYOUNG
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Multicenter clinical trials for TSC & related disorders
|
5R01CA107164-04
|
$181,066
|
$90,533
|
DABORA, SANDRA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Development and Validation of a FISH-Based Renal Cancer Detection Assay
|
1R44CA134103-01
|
$93,253
|
$93,253
|
HOULDSWORTH, JANE
|
CANCER GENETICS, INC.
|
|
Carle Cancer Center Community Clinical Oncology Program
|
2U10CA035195-25
|
$855,703
|
$8,557
|
ROWLAND, KENDRITH
|
CARLE CLINIC ASSOCIATION, P C
|
|
Eastern Cooperative Oncology Group Studies
|
5U10CA014548-34
|
$417,899
|
$33,432
|
AVERBOOK, BRUCE
|
CASE WESTERN RESERVE UNIVERSITY
|
|
AACR-TREC-NIH Think Tank Conference: Energy Balance and Cancer; Mechanisms and Me
|
1R13CA134016-01
|
$10,000
|
$2,000
|
Berger, Nathan
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Cedar Rapids Oncology Project
|
2U10CA052352-19
|
$575,627
|
$5,756
|
WIESENFELD, MARTIN
|
CEDAR RAPIDS ONCOLOGY PROJECT
|
|
Genetics of pediatric rhabdoid tumors
|
2R01CA046274-17A2
|
$266,860
|
$90,732
|
BIEGEL, JACLYN
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
PSYCHOLOGICAL OUTCOME IN CHILDHOOD CANCER SURVIVORS
|
5R01CA106928-05
|
$344,888
|
$34,489
|
KAZAK, ANNE
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
Delaware/Christiana Care CCOP
|
5U10CA045418-22
|
$1,042,698
|
$10,427
|
Grubbs, Stephen
|
CHRISTIANA CARE HEALTH SERVICES, INC.
|
|
Tumor Induced Dysregulation of T Cell Immunity
|
5R01CA116255-03
|
$261,665
|
$261,665
|
FINKE, JAMES
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
Therapeutic Modulation of COX-2-induced Immunosuppression in Metastatic RCC
|
5R21CA123854-02
|
$293,550
|
$293,550
|
RINI, BRIAN
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
Tumor Gangliosides and TNF Synergize for T Cell Death
|
5R01CA111917-04
|
$257,865
|
$257,865
|
TANNENBAUM, CHARLES
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
CCOP: Colorado Cancer Research Program
|
5U10CA067753-13
|
$873,364
|
$8,734
|
Pajon, Eduardo
|
COLORADO CANCER RESEARCH PROGRAM, INC.
|
|
The role of angiopoietins in Wilms tumor
|
5K08CA107077-04
|
$134,946
|
$134,946
|
HUANG, JIANZHONG
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Genomic and Epigenomic Profiling by MSNP
|
5R21CA128556-02
|
$241,500
|
$60,375
|
Tycko, Benjamin
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Columbus Community Clinical Oncology Program
|
5U10CA035261-25
|
$874,908
|
$8,749
|
KUEBLER, J
|
COLUMBUS COMMUNITY CLINICAL ONCOLOGY PRG
|
|
Statistical Methods for Cancer Research
|
5R01CA066218-28
|
$160,546
|
$16,055
|
Turnbull, Bruce
|
CORNELL UNIVERSITY ITHACA
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S1
|
$124,531
|
$1,245
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S2
|
|
$0
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S3
|
$49,998
|
$500
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S4
|
$143,383
|
$1,434
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S5
|
|
$0
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA006516-44
|
$11,641,774
|
$116,418
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
The MiT Transcription Factor in Pediatric Malignancies
|
5R01CA102309-05
|
$299,147
|
$149,574
|
FISHER, DAVID
|
DANA-FARBER CANCER INSTITUTE
|
|
ECOG Statistical Office
|
5U10CA023318-32
|
$2,367,125
|
$189,370
|
GRAY, ROBERT
|
DANA-FARBER CANCER INSTITUTE
|
|
Functional Analysis of the Von Hippel-Lindau Protein
|
5R01CA068490-13
|
$297,903
|
$297,903
|
KAELIN, WILLIAM
|
DANA-FARBER CANCER INSTITUTE
|
|
Cellular Consequences of Snf5 Tumor Suppressor Loss
|
5F32CA123776-02
|
$54,842
|
$54,842
|
Sansam, Courtney
|
DANA-FARBER CANCER INSTITUTE
|
|
Immunotherapy for Renal Cell Carcinoma
|
2R01CA095648-04A1
|
$394,585
|
$394,585
|
ERNSTOFF, MARC
|
DARTMOUTH COLLEGE
|
|
Cancer Center Support Grant
|
3P30CA023108-30S1
|
$88,511
|
$1,770
|
ISRAEL, MARK
|
DARTMOUTH COLLEGE
|
|
Cancer Center Support Grant
|
5P30CA023108-30
|
$3,107,727
|
$62,155
|
ISRAEL, MARK
|
DARTMOUTH COLLEGE
|
|
Dissection of the DNA damage checkpoint pathways
|
5R01CA084463-09
|
$307,019
|
$15,351
|
Sanchez, Yolanda
|
DARTMOUTH COLLEGE
|
|
Central Illinois Community Clinical Oncology Program
|
5U10CA045807-23
|
$1,053,633
|
$10,536
|
WADE, JAMES
|
DECATUR MEMORIAL HOSPITAL
|
|
Eastern Cooperative Oncology Group Chair's Office
|
5U10CA086802-10
|
$644,464
|
$51,557
|
COMIS, ROBERT
|
DREXEL UNIVERSITY
|
|
Duke Comp Cancer Ctr Core Support Grant
|
3P30CA014236-34S1
|
$40,000
|
$400
|
LYERLY, HERBERT
|
DUKE UNIVERSITY
|
|
Duke Comp Cancer Ctr Core Support Grant
|
3P30CA014236-34S2
|
|
$0
|
LYERLY, HERBERT
|
DUKE UNIVERSITY
|
|
Duke Comp Cancer Ctr Core Support Grant
|
3P30CA014236-34S3
|
$249,999
|
$2,500
|
LYERLY, HERBERT
|
DUKE UNIVERSITY
|
|
Duke Comp Cancer Ctr Core Support Grant
|
3P30CA014236-34S4
|
$85,106
|
$851
|
LYERLY, HERBERT
|
DUKE UNIVERSITY
|
|
Duke Comp Cancer Ctr Core Support Grant
|
3P30CA014236-34S5
|
$100,000
|
$1,000
|
LYERLY, HERBERT
|
DUKE UNIVERSITY
|
|
Duke Comp Cancer Ctr Core Support Grant
|
5P30CA014236-34
|
$6,558,287
|
$65,583
|
LYERLY, HERBERT
|
DUKE UNIVERSITY
|
|
Molecular Mechanisms of E2F Specificity
|
2R01CA104663-06
|
$338,986
|
$338,986
|
NEVINS, JOSEPH
|
DUKE UNIVERSITY
|
Total relevant funding to Kidney Disease for this search: $43,431,683
|